Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 14, 2009

View Archived Issues

An exploratory memantine trial in amyotrophic lateral sclerosis produces discouraging results

KNS-760704 is well tolerated and may be beneficial in treating amyotrophic lateral sclerosis

Recent studies of dengue vaccines presented at the ASTMH meeting

NanoPacific Holdings acquires license from UCLA for supramolecular nanoparticles

CSL and Sanofi Pasteur are developing vaccine to treat gum disease

Sanofi Pasteur expands global clinical program of its dengue vaccine

GSK initiates second pivotal phase III trial of darapladib

QLT reports results of EVEREST trial of Visudyne(R) in polypoidal choroidal vasculopathy

Repligen reports phase III trial results of RG-1068 in pancreatic imaging

Targacept initiates phase II proof-of-concept trial of TC-5619 in schizophrenia

Algeta initiates phase III ALSYMPCA trial of Alpharadin in CRPC in the U.S.

GSK and Intercell collaborate to develop needle-free, patch-based vaccines

Daiichi reports on phase III trial of edoxaban to prevent postoperative venous thromboembolism

Johnson & Johnson reports results from phase III trial of Invega Sustenna in schizophrenia

AstraZeneca describes TAK1 inhibitor with potential for treating mantle cell lymphoma

Basilea's Toctino recommended for approval for hand eczema in additional E.U. countries

NDDPX-08 increases survival and delays disease progression in mouse model of ALS

European Commission grants marketing authorization to Pfizer's Prevenar 13 vaccine

MediGene presents update on clinical development of EndoTAG-1 and RhuDex

University of California, Oakland discloses neuraminidase inhibitors for avian influenza

Arpida completes merger with Evolva

Novartis presents novel ALK inhibitors for treatment of pulmonary hypertension

Takeda identifies novel kinase inhibitors for the treatment of cancer

Aztreonam for inhalation solution recommended for approval by FDA advisory committee

Cubist Pharmaceuticals to acquire Calixa Therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...